MIRIAM DELOSANTOS: Open Payments
NPI 1992991095 · VENTURA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 19 payments from 13 companies in 2025. Trend: 2023 $285 · 2024 $63 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $99 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Lilly USA, LLC | 2 | $46 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Sage Therapeutics, LLC | 2 | $36 |
| Exact Sciences Corporation | 2 | $33 |
| Teleflex LLC | 1 | $32 |
| Gilead Sciences, Inc. | 1 | $31 |
| Novo Nordisk Inc | 1 | $28 |
| Dexcom, Inc. | 1 | $27 |
Products named: Veozah, MOUNJARO, AIRSUPRA, ZURZUVAE, Cologuard Collection Kit, UROLIFT, Wegovy, Dexcom G6 Transmitter.
Industry payments across CA — which companies pay providers there.
